Safety and value driving Phase IV growth at CROs; EVP
Increased focus on post-market safety and value has resulted in CROs handling more Phase IV work, according to a PharmaNet EVP, and this trend may continue as regulators seek real world evidence.
Archives for June 2, 2010
Cambrex receives FDA approval for Iowa site
American chemicals maker Cambrex has announced its active pharmaceutical ingredient (API) manufacturing facility has completed a successful FDA inspection.
USP forges stronger links with Ukraine and Russia
The USP is strengthening links with Eastern Europe and Russia by agreeing to share quality standards with Ukraine and offering training courses in Moscow.
X-ray transparent belt boosts performance on contaminant detection lines
X-ray transparency and added durability are benefits of a new conveyor belt that helps improve performance for contaminant detection in glass containers on food and pharmaceutical lines, said Mettler Toledo Safeline.
XClinical launches tool to simplify case report form design
Germany-based XClinical has introduced the ODM Study Composer to simplify and accelerate the design of electronic case report forms (eCRF).
NAFDAC keen on new SMS anti-counterfeit results
An anti-counterfeiting pilot project in Nigeria, which uses a mobile authentication service (MAS) to validate genuine medication, has completed a 100-day pilot phase. Preliminary results suggest the scheme is well on the way to becoming an effective...
Celerion adds ECG lab to save time & money in Phase I
Celerion has implemented a hybrid ECG core lab across its Phase I network to help clients get through this early developmental stage “much cheaper and much faster”.
Malaysia seeks to attract Indian pharma manufacturers
Malaysia is keen to attract Indian biopharm companies and is offering incentives and infrastructure to encourage firms to establish manufacturing operations, according to local media reports.
Novella buys Prologue to strengthen oncology services
US-based contract research organisation (CRO) Novella Clinical has acquired Prologue Research to enhance its offering of oncology clinical trial services.